Sandoz Misled About FDA Approval Of Drug, Competitors Say
Lehigh Valley Technologies Inc. and Endo Global Ventures sued generic-drug manufacturer Sandoz Inc. in New Jersey federal court on Wednesday over a potassium supplement that they say was never approved by...To view the full article, register now.
Already a subscriber? Click here to view full article